Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
World J Microbiol Biotechnol ; 35(3): 41, 2019 Feb 14.
Article in English | MEDLINE | ID: mdl-30762133

ABSTRACT

L-asparaginase is an enzyme capable of hydrolyzing the substrate asparagine in aspartic acid and ammonia. Due to this mechanism of action observed, L-asparaginase is widely used in the treatment of Acute Lymphoblastic Leukemia, since these cells use asparagine for their survival. Because it is frequently used as an antineoplastic, it is necessary to evaluate its genotoxic effects. The aim of the present study was to evaluate cellular DNA damage after exposure to L-asparaginase produced by Streptomyces ansochromogenes UFPEDA 3420. NCIH-292, MCF-7 and MOLT-4 neoplastic cell lines and normal PBMC cells were used. L-Asparaginase used in this study was produced by actinobacteria S. ansochromogenes UFPEDA 3420, isolated and purified by chromatographic methods. L-Asparaginase induced micronucleus formation in PBMC cells and tumor lines when compared to the negative control. These data suggest that L-Asp appears to have a genotoxic effect very close to the positive control in normal cells (p < 0.05). The level of genomic damage measured by DNA breaks in alkaline SCGE assay was detected from the lowest concentration (12.5 µg/mL) to the highest concentration (50 µg/mL) for tumor cell lines and PBMC. In view of the above, new genotoxic studies will be carried out to better elucidate L-Asparaginase and its mutagenic potential, still unknown, enough for this drug to be safely used in conventional antineoplastic therapies.


Subject(s)
Antineoplastic Agents/pharmacology , Asparaginase/pharmacology , DNA Damage/drug effects , Streptomyces/enzymology , Streptomyces/metabolism , Asparaginase/isolation & purification , Asparagine/metabolism , Aspartic Acid/metabolism , Cell Line, Tumor/drug effects , Enzyme Assays , Humans , Inhibitory Concentration 50 , Leukocytes, Mononuclear/drug effects , Micronucleus Tests
2.
Anticancer Res ; 35(6): 3325-32, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26026092

ABSTRACT

Prodigiosin is a secondary metabolite produced by Serratia marcercens. As this pigment is suggested to be a cancer drug, genotoxicity studies are necessary. The aim of the present investigation was to evaluate the genotoxic effects of prodigiosin on tumoral and normal cell lines, NCIH-292, MCF-7 and HL-60. A normal line BGMK was used as control. Genomic damage induced by prodigiosin was observed in all tumor lines as well as the control line. The pigment induced the formation of micronuclei in tumor cells. The present data confirm the antitumor potential of prodigiosin. However, these findings also raise concerns regarding its target-specific action, as genotoxic effects on normal cells also occurred.


Subject(s)
DNA Damage/drug effects , Genome, Human/drug effects , Neoplasms/drug therapy , Prodigiosin/administration & dosage , Humans , MCF-7 Cells , Neoplasms/pathology , Prodigiosin/adverse effects , Serratia/chemistry , Serratia/pathogenicity , Serratia Infections/complications , Serratia Infections/drug therapy , Serratia Infections/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...